Multistate Salmonella Outbreak Linked to Sweet Cream Mini Pastries

The Sweet Cream-brand mini pastries were manufactured in Italy and exported into the United States by Importations Piu Che Dolci Inc. of Quebec, Canada.

recalled pastry

Photo courtesy FDA

The FDA and CDC, in collaboration with state, local and international partners, are investigating illnesses in a multistate outbreak of Salmonella Enteritidis infections linked to Sweet Cream-brand mini pastries manufactured in Italy and exported into the United States by Importations Piu Che Dolci Inc. of Quebec, Canada.

On Jan. 21, FDA was notified about an outbreak of Salmonella in the United States, which is the same strain investigated in Canada. Canadian Food Inspection Agency (CFIA) informed FDA that its investigation linked their outbreak to Sweet Cream-brand mini pastries, and Importations Piu Che Dolci Inc. initiated a recall of all Sweet Cream-brand mini pastry products with best by dates from June 17 through Nov. 15.

The recalled products were imported by two distributors in the U.S. who were contacted about the recall. One distributor had no product on hand, and the second distributor quarantined all product on hand and informed all of its downstream customers of the recall.

As part of this investigation, FDA conducted traceback for one of the U.S. cases and identified that they were served recalled Sweet Cream-brand mini pastries at a restaurant prior to becoming sick. The restaurant received the pastries from one of the U.S. distributors.

As of Jan. 29, a total of 18 people infected with the outbreak strain of Salmonella have been reported from seven states. Of the 18 people for whom information is available, one person has been hospitalized. No deaths have been reported. Of the five people interviewed, three (60%) reported eating pastries.

Food service customers who received the recalled product have been contacted directly. FDA is continuing to work with Importations Piu Che Dolci Inc. and its U.S. customers to determine the distribution of this product and if additional downstream recalls are necessary. The recalled product should no longer be available for sale, and there does not appear to be a continued public health risk for consumers.

FDA’s investigation is ongoing, and more information will be provided as it becomes available. Read the full report here